CountryFocus: Healthcare, Regulatory and Reimbursement Landscape -Mexico

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Mexico”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Mexico. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Mexico. Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Mexico, and includes:

  • An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
  • Profiles and SWOT analyses of the major players in the pharmaceutical market (Boehringer Ingelheim, Bayer, Pfizer, GSK, and Genomma Lab) and profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche Diagnostics, Essilor, Zimmer Biomet and Abbott)
  • Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Mexico
  • Porter’s five forces analysis for pharmaceutical and medical devices market of Mexico
  • An insightful review of the reimbursement and regulatory landscape, of which analysis includes details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
  • Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
  • An overview of the opportunities and challenges to growth in the Mexican healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to:

  • Develop business strategies by understanding the trends shaping and driving the Mexican healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
  • Identify, understand, and capitalize on the opportunities and challenges in the Mexican healthcare market

Table of Contents

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary – Overview

2.2 Key Highlights

2.3 Key ...

1 Table of Contents

1.1 List of Figures

1.2 List of Tables

2 Executive Summary

2.1 Executive Summary – Overview

2.2 Key Highlights

2.3 Key Events: Mexican Pharmaceutical History, 2012–2018

2.4 Key Events: Mexican Pharmaceutical Market

2.5 Key Events: M&A, VF & PE Deals, Global Pharmaceutical Market, 2018–2019

2.6 Key Events: Mergers and Acquisitions

2.7 Country Profile, Mexico, 2018

3 Overview of Pharmaceutical Market

3.1 Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Exports

3.3 Pharmaceutical Market – Imports

3.4 Pharmaceutical Market – Supply Channels

3.5 Pharmaceutical Market – Market Segments

3.6 Pharmaceutical Market – Major Health Services

3.7 Pharmaceutical Market – Major Players

4 Overview of Medical Devices Market

4.1 Medical Device Market – Overview

4.2 Medical Device Market – Top Five Segments

4.3 Medical Device Market – Diagnostic Market

4.4 Medical Device Market – Major Players

5 Pharmaceutical and Medical Device Market – Drivers and Barriers

5.1 Drivers

5.2 Barriers

6 Deal analysis

6.1 Deal Analysis: M&A, VF and PE Deals, Pharmaceutical Market, Mexico

6.2 Deal Analysis: M&A, VF and PE Deals, Medical Device Market, Mexico

7 Pharmaceutical and Medical Device Market – Porter’s Five Forces Analysis

7.1 Pharmaceutical Market, Mexico – Porter’s Five Forces Analysis

7.2 Medical Device Market, Mexico – Porter’s Five Forces Analysis

8 Market Access

8.1 Overview of Healthcare System, Mexico

8.2 Reimbursement Process, Mexico

8.2.1 Overview of Insurance, Mexico

8.2.2 Healthcare Spending and Medical Products Price Index, Mexico

8.2.3 Pricing Policies, Mexico

8.3 Regulatory Landscape, Mexico

8.3.1 Market Authorization for Pharmaceutical Drugs, Mexico

8.3.2 Market Authorization for Medical Devices, Mexico

8.3.3 Intellectual Property Rights, Patent, Mexico

8.3.4 Intellectual Property Rights, Trademark, Mexico

8.3.5 Clinical Trial Regulations, Mexico

8.3.6 Pharmaceutical Advertising Regulations, Mexico

8.3.7 Labeling and Packaging Regulations, Mexico

9 Country Healthcare Landscape

9.1 Healthcare Policy Highlights

9.2 Healthcare Facilities

9.3 Healthcare Parameters

9.4 Environmental Health

9.5 Healthcare Personnel

9.6 Disease Burden

9.7 Healthcare Expenditure

10 Trade Associations, Mexico

11 Trade Fairs, Mexico

12 Opportunities and Challenges

13 Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.1.4 Expert Panel

13.2 Bibliography

13.3 Contact Us

13.4 Disclaimer

List of Tables

Table 1: Ophthalmic Devices Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2015

Table 2: Orthopedic Devices Market, Mexico, Revenue ($m) and ...

Table 1: Ophthalmic Devices Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2015

Table 2: Orthopedic Devices Market, Mexico, Revenue ($m) and Market Share (%) of Major Companies, 2018

Table 3: Hospital Supplies Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2017

Table 4: In Vitro Diagnostics Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2018

Table 5: General Surgery Devices Market, Mexico, Revenue ($M) and Market Share (%) of Major Companies, 2018

Table 6: Approval Timelines, Mexico, 2019

Table 7: Medical Device Classification, Mexico, 2018

Table 8: Approval Process, Mexico, 2018

Table 9: Patent Fees, Mexico, 2019

Table 10: Trade Fairs, Mexico, 2019

List of Figures

Figure 1: Pharmaceutical Market, Mexico, Revenue ($B), 2010–2017

Figure 2: Medical Device Market, Mexico, Revenue ($B), 2015–2020

Figure 3: Country Profile, Mexico, 2018

Figure 4: ...

Figure 1: Pharmaceutical Market, Mexico, Revenue ($B), 2010–2017

Figure 2: Medical Device Market, Mexico, Revenue ($B), 2015–2020

Figure 3: Country Profile, Mexico, 2018

Figure 4: Pharmaceutical Market, Mexico, Revenue ($B), 2010–2017

Figure 5: Pharmaceutical Market, Mexico, Revenue Forecast ($B), 2018–2022

Figure 6: Pharmaceutical Exports ($B), Mexico, 2010–2018

Figure 7: Top Export Partners, Mexico, 2018

Figure 8: Pharmaceutical Imports ($B), Mexico, 2010–2018

Figure 9: Top Import Partners, Mexico, 2018

Figure 10: Pharmaceutical Supply Chain, Mexico, 2019

Figure 11: Major Health Services (%), Mexico, 2016

Figure 12: Pharmaceutical Market, Major Players, 2017

Figure 13: Medical Device Market, Mexico, Revenue ($B), 2015–2020

Figure 14: Medical Device Market, Mexico, Revenue Forecast ($B), 2021–2025

Figure 15: Medical Device Market, Mexico, Revenue by Segment ($M), 2018

Figure 16: Ophthalmic Devices Market, Mexico, Revenue ($M), 2015–2022

Figure 17: Ophthalmic Devices Market, Mexico, Market Share of Major Players (%), 2015

Figure 18: Orthopedic Devices Market, Mexico, Revenue ($M), 2015–2022

Figure 19: Orthopedic Devices Market, Mexico, Market Share of Major Companies (%), 2018

Figure 20: Hospital Supplies Market, Mexico, Revenue ($M), 2015–2022

Figure 21: Hospital Supplies Market, Mexico, Market Share of Major Players (%), 2017

Figure 22: In Vitro Diagnostics Market, Mexico, Revenue ($M), 2015–2022

Figure 23: In Vitro Diagnostics Market, Mexico, Market Share of Major Players (%), 2018

Figure 24: General Surgery Devices Market, Mexico, Revenue ($M), 2015–2022

Figure 25: General Surgery Devices Market, Mexico, Market Share of Major Players (%), 2018

Figure 26: Diagnostic Market, Mexico, Revenue ($B), 2015–2020

Figure 27: Diagnostic Market, Mexico, Revenue ($B), 2021–2025

Figure 28: Medical Device Market, Mexico, Revenue ($B) of Major Companies, 2017

Figure 29: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Mexico, 2018–2019

Figure 30: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Mexico,2018–2019

Figure 31: M&A Deals by Therapy Area, Pharmaceutical Market, Mexico,

2018–2019(by value and by number)

Figure 32: Medical Device Market Deals (by Deal Value and Deal Count, $M), Mexico, 2018

Figure 33: Medical Device Market Deals, Top Therapy Area by Deal Value and Count , Mexico, 2018

Figure 34: Medical Device Market Deals , (by Deal Value and Count), Mexico, 2018

Figure 35: Medical Device Market Deals, Mexico, Venture Financing Deals by Therapy Area, 2018

Figure 36: Organization of the Health System, Mexico, 2018

Figure 37: Reimbursement Pricing for New Drugs, Mexico, 2018

Figure 38: Out-of-Pocket Expenditure (% of total expenditure on health), Mexico, 2010–2016

Figure 39: Annual Rate of Change (%), Health and Welfare Services Price Index, Mexico, 2012–2018

Figure 40: Number of companies participating in CCNPMIS process and number of products negotiated, Mexico, 2008–2015

Figure 41: Drug Registration Types and Data Requirements, Mexico, 2018

Figure 42: Drug Approval Process, Mexico, 2018

Figure 43: Patent Approval Timeline, Mexico, 2016

Figure 44: Patent Approval Process, Mexico, 2016

Figure 45: Trademark Process, Mexico, 2017

Figure 46: Clinical Trial Regulations, Mexico, 2018

Figure 47: Advertising Regulations, Mexico, 2018

Figure 48: Hospitals (number), Mexico, 2010–2017

Figure 49: Hospitals by Type (number), Mexico, 2010–2017

Figure 50: Diagnostic Equipment (units per million population), Mexico, 2010–2017

Figure 51: Hospital Beds (per 1,000 population), Mexico, 2010–2017

Figure 52: Acute Care Hospital Beds (per 1,000 population), Mexico, 2010–2017

Figure 53: Psychiatric Care Hospital Beds (per 1,000 population), Mexico, 2010–2017

Figure 54: Life Expectancy (in years), Mexico, 2010–2017

Figure 55: Immunization Rate (%), Mexico, 2010–2017

Figure 56: PM2.5 (µg per m3), Mexico, 2010–2017

Figure 57: CO2 Emissions (metric tons per capita), Mexico, 2010–2017

Figure 58: Physicians (per 1,000 population), Mexico, 2010-2017

Figure 59: Nurses (per 1,000 population), Mexico, 2010-2017

Figure 60: Dentists, (per 1,000 population), Mexico, 2010-2017

Figure 61: Major Causes of Mortality (Number of deaths), Mexico, 2016

Figure 62: Major Causes of Male Mortality (Number of deaths), Mexico, 2016

Figure 63: Major Causes of Female Mortality (Number of deaths), Mexico, 2016

Figure 64: Disability-Adjusted Life Years by Major Disease (‘000), Mexico, 2016

Figure 65: Healthcare Expenditure as Percentage of GDP (%), Mexico, 2010–2017

Figure 66: Health Expenditure Share (% of total health spending), Mexico, 2010–2017

Figure 67: Healthcare spending as per providers (%), Mexico, 2016

Figure 68: Pharmaceutical Spending (% of total health spending), Mexico, 2011–2016

Figure 69: Opportunities & Challenges, Mexico

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports

Willingness to listen to our questions and develop Pharma eTrack.

  GlaxoSmithKline